[PDF][PDF] 术前BRAF V600E 检测对甲状腺乳头状癌病理结局的预测价值
王敏， 张威浩， 刘俊， 杨烨， 师晓琴 - 肿瘤, 2022 - tumorsci.org
… significant difference in gross extrathyroid extension (gETE) … , age, tumor maximum diameter,
tumor multifocal and lymph node … ,将ETE 分 为镜下ETE(microscopic ETE,mETE)和明 显ETE(…
tumor multifocal and lymph node … ,将ETE 分 为镜下ETE(microscopic ETE,mETE)和明 显ETE(…
2015 年美国甲状腺学会《 成人甲状腺结节与分化型甲状腺癌诊治指南》 解读: 分化型甲状腺癌131I 治疗新进展
林岩松， 李娇 - 中国癌症杂志, 2016 - china-oncology.com
… papillary thyroid carcinoma: single-institution results from a large … in predicting papillary
thyroid carcinoma recurrence [J]. … aggressive papillary thyroid cancer with highest recurrence [J…
thyroid carcinoma recurrence [J]. … aggressive papillary thyroid cancer with highest recurrence [J…
碘-125 粒子植入治疗碘难治性分化型甲状腺癌淋巴结转移灶的临床研究
李敏， 文鹏， 钱秋琴， 秦昂， 曾理， 石峰 - 中国癌症杂志, 2020 - china-oncology.com
… Results: After treatment, the objective remission rate of 39 patients was 43.6%, and the disease
control rate was … lymph nodes recurrence from esophageal carcinoma: effectiveness and …
control rate was … lymph nodes recurrence from esophageal carcinoma: effectiveness and …